시장보고서
상품코드
1283873

세계의 파라세타몰 시장(2023-2027년)

Global Paracetamol Market 2023-2027

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 156 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

파라세타몰(Paracetamol) 시장은 2022-2027년 7억 9,190만 달러, 예측 기간 중 CAGR은 8.78%로 예측됩니다.

파라세타몰 시장에 관한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인·과제 및 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 전체의 환경에 관한 최신 분석을 제공하고 있습니다. 파라세타몰은 많은 일반의약품에 원료의약품으로서 사용되고 있는 것, 증상 완화를 위한 제일 선택약으로서 널리 응용되고 있는 것, 만성질환 및 처방약의 사용률이 상승하고 있는 것이 시장을 촉진하고 있습니다.

본 조사에서는 파라세타몰에 기반한 조합의 승인 수가 증가하고 있는 것이 향후 수년간 파라세타몰 시장의 성장을 촉진하는 주요 이유의 하나라고 지적하고 있습니다. 또한 헬스케어 지출의 증가 및 새로운 파라세타몰 애플리케이션 개척은 시장의 큰 수요로 연결될 것으로 전망되고 있습니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 에코시스템

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 2022
  • 시장 전망 2022-2027

제4장 시장 규모 실적

  • 세계의 파라세타몰 시장 2017-2021
  • 용도별 부문 분석 2017-2021
  • 제제 부문 분석 2017-2021
  • 지역별 부문 분석 2017-2021
  • 국가별 부문 분석 2017-2021

제5장 Five forces 분석

  • Five Forces 요약
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 현황

제6장 시장 세분화 : 용도별

  • 시장 부문
  • 비교 : 용도별
  • 외과적 : 시장 규모와 예측 2022-2027
  • 비외과적 : 시장 규모와 예측 2022-2027
  • 시장 기회 : 용도별

제7장 시장 세분화 배합별

  • 시장 부문
  • 비교 배합별
  • 분말 : 시장 규모와 예측 2022-2027
  • 과립 : 시장 규모와 예측 2022-2027
  • 시장 기회 배합별

제8장 고객 상황

  • 고객 상황의 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측 2022-2027
  • 유럽 : 시장 규모와 예측 2022-2027
  • 아시아 : 시장 규모와 예측 2022-2027
  • 세계의 기타 지역 : 시장 규모와 예측 2022-2027
  • 미국 : 시장 규모와 예측 2022-2027
  • 중국 : 시장 규모와 예측 2022-2027
  • 영국 : 시장 규모와 예측 2022-2027
  • 독일 : 시장 규모와 예측 2022-2027
  • 인도 : 시장 규모와 예측 2022-2027
  • 지역 상황별 시장 기회

제10장 촉진요인, 과제 및 동향

  • 시장 촉진요인
  • 시장이 해결해야 할 과제
  • 촉진요인과 과제의 영향
  • 시장 동향

제11장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란의 상황
  • 업계의 리스크

제12장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Anhui Fubore Pharmaceutical And Chemical Co. Ltd.
  • Anqiu Luan Pharmaceutical Co. Ltd.
  • ATABAY KIMYA SANAYI TICARET AS
  • Biological E. Ltd.
  • Cipla Ltd.
  • GlaxoSmithKline Plc
  • Granules India Ltd.
  • Mallinckrodt Plc
  • Sanofi SA
  • SEQENS GROUP
  • Sri Krishna Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zhejiang Kangle Pharmaceutical Co. Ltd.
  • Zhengzhou Sino Chemical Co. Ltd.

제13장 부록

KSA 23.06.08

The paracetamol market is forecasted to grow by USD 791.9 mn during 2022-2027, accelerating at a CAGR of 8.78% during the forecast period. The report on the paracetamol market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the significant use of paracetamol as API in a large number of otc drugs, the wide application of paracetamol as first-line therapy for symptomatic relief, and the rising prevalence of chronic conditions and prescription drug use.

Technavio's paracetamol market is segmented as below:

By Application

  • Surgical
  • Non-surgical

By Formulation

  • Powder
  • Granules

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing number of approvals for paracetamol-based combinations as one of the prime reasons driving the paracetamol market growth during the next few years. Also, increasing healthcare expenditure and developments in new paracetamol applications will lead to sizable demand in the market.

The report on the paracetamol market covers the following areas:

  • Paracetamol market sizing
  • Paracetamol market forecast
  • Paracetamol market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading paracetamol market vendors that include Anhui Fubore Pharmaceutical And Chemical Co. Ltd., Anqiu Luan Pharmaceutical Co. Ltd., ATABAY KIMYA SANAYI TICARET AS, Biological E. Ltd., Cipla Ltd., GlaxoSmithKline Plc, Granules India Ltd., Mallinckrodt Plc, Sanofi SA, SEQENS GROUP, Sri Krishna Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Trugen Pharmaceuticals Pvt Ltd., Zhejiang Kangle Pharmaceutical Co. Ltd., and Zhengzhou Sino Chemical Co. Ltd.. Also, the paracetamol market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Formulation
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global paracetamol market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global paracetamol market 2017 - 2021 ($ million)
  • 4.2 Application Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
  • 4.3 Formulation Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Formulation Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

  • 6.1 Market segments
  • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
  • 6.2 Comparison by Application
  • Exhibit 32: Chart on Comparison by Application
  • Exhibit 33: Data Table on Comparison by Application
  • 6.3 Surgical - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Surgical - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Surgical - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Surgical - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Surgical - Year-over-year growth 2022-2027 (%)
  • 6.4 Non-surgical - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Non-surgical - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Non-surgical - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Non-surgical - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Non-surgical - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Application
  • Exhibit 42: Market opportunity by Application ($ million)
  • Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Formulation

  • 7.1 Market segments
  • Exhibit 44: Chart on Formulation - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Formulation - Market share 2022-2027 (%)
  • 7.2 Comparison by Formulation
  • Exhibit 46: Chart on Comparison by Formulation
  • Exhibit 47: Data Table on Comparison by Formulation
  • 7.3 Powder - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Powder - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Powder - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Powder - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Powder - Year-over-year growth 2022-2027 (%)
  • 7.4 Granules - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Granules - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Granules - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Granules - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Granules - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Formulation
  • Exhibit 56: Market opportunity by Formulation ($ million)
  • Exhibit 57: Data Table on Market opportunity by Formulation ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
  • Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 India - Market size and forecast 2022-2027
  • Exhibit 95: Chart on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on India - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 99: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 Anhui Fubore Pharmaceutical And Chemical Co. Ltd.
  • Exhibit 107: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Overview
  • Exhibit 108: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Product / Service
  • Exhibit 109: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Key offerings
  • 12.4 Anqiu Luan Pharmaceutical Co. Ltd.
  • Exhibit 110: Anqiu Luan Pharmaceutical Co. Ltd. - Overview
  • Exhibit 111: Anqiu Luan Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 112: Anqiu Luan Pharmaceutical Co. Ltd. - Key offerings
  • 12.5 ATABAY KIMYA SANAYI TICARET AS
  • Exhibit 113: ATABAY KIMYA SANAYI TICARET AS - Overview
  • Exhibit 114: ATABAY KIMYA SANAYI TICARET AS - Product / Service
  • Exhibit 115: ATABAY KIMYA SANAYI TICARET AS - Key offerings
  • 12.6 Biological E. Ltd.
  • Exhibit 116: Biological E. Ltd. - Overview
  • Exhibit 117: Biological E. Ltd. - Product / Service
  • Exhibit 118: Biological E. Ltd. - Key offerings
  • 12.7 Cipla Ltd.
  • Exhibit 119: Cipla Ltd. - Overview
  • Exhibit 120: Cipla Ltd. - Business segments
  • Exhibit 121: Cipla Ltd. - Key news
  • Exhibit 122: Cipla Ltd. - Key offerings
  • Exhibit 123: Cipla Ltd. - Segment focus
  • 12.8 GlaxoSmithKline Plc
  • Exhibit 124: GlaxoSmithKline Plc - Overview
  • Exhibit 125: GlaxoSmithKline Plc - Business segments
  • Exhibit 126: GlaxoSmithKline Plc - Key news
  • Exhibit 127: GlaxoSmithKline Plc - Key offerings
  • Exhibit 128: GlaxoSmithKline Plc - Segment focus
  • 12.9 Granules India Ltd.
  • Exhibit 129: Granules India Ltd. - Overview
  • Exhibit 130: Granules India Ltd. - Product / Service
  • Exhibit 131: Granules India Ltd. - Key news
  • Exhibit 132: Granules India Ltd. - Key offerings
  • 12.10 Mallinckrodt Plc
  • Exhibit 133: Mallinckrodt Plc - Overview
  • Exhibit 134: Mallinckrodt Plc - Business segments
  • Exhibit 135: Mallinckrodt Plc - Key news
  • Exhibit 136: Mallinckrodt Plc - Key offerings
  • Exhibit 137: Mallinckrodt Plc - Segment focus
  • 12.11 Sanofi SA
  • Exhibit 138: Sanofi SA - Overview
  • Exhibit 139: Sanofi SA - Business segments
  • Exhibit 140: Sanofi SA - Key news
  • Exhibit 141: Sanofi SA - Key offerings
  • Exhibit 142: Sanofi SA - Segment focus
  • 12.12 SEQENS GROUP
  • Exhibit 143: SEQENS GROUP - Overview
  • Exhibit 144: SEQENS GROUP - Product / Service
  • Exhibit 145: SEQENS GROUP - Key offerings
  • 12.13 Sri Krishna Pharmaceuticals Ltd.
  • Exhibit 146: Sri Krishna Pharmaceuticals Ltd. - Overview
  • Exhibit 147: Sri Krishna Pharmaceuticals Ltd. - Product / Service
  • Exhibit 148: Sri Krishna Pharmaceuticals Ltd. - Key offerings
  • 12.14 Sun Pharmaceutical Industries Ltd.
  • Exhibit 149: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 150: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 151: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 12.15 Teva Pharmaceutical Industries Ltd.
  • Exhibit 152: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 153: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 154: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 156: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 12.16 Zhejiang Kangle Pharmaceutical Co. Ltd.
  • Exhibit 157: Zhejiang Kangle Pharmaceutical Co. Ltd. - Overview
  • Exhibit 158: Zhejiang Kangle Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 159: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key offerings
  • 12.17 Zhengzhou Sino Chemical Co. Ltd.
  • Exhibit 160: Zhengzhou Sino Chemical Co. Ltd. - Overview
  • Exhibit 161: Zhengzhou Sino Chemical Co. Ltd. - Product / Service
  • Exhibit 162: Zhengzhou Sino Chemical Co. Ltd. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 163: Inclusions checklist
  • Exhibit 164: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 165: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 166: Research methodology
  • Exhibit 167: Validation techniques employed for market sizing
  • Exhibit 168: Information sources
  • 13.5 List of abbreviations
  • Exhibit 169: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제